ADMA Biologics News - November 5, 2026

🟢 ADMA Biologics is trading 25% up after raising full-year adjusted earnings outlook

ADMA Biologics is trading at $13.09 (+24.90%) on November 5 after reporting third-quarter results and raising its full-year adjusted earnings outlook. -...

🟢 ADMA Biologics is trading 22.23% up in pre-market after stronger third-quarter results and raised profit outlook

ADMA Biologics is trading at $12.81, up 22.23% in pre-market on November 5 after its third-quarter report, released after the November 4 close, raised minimum...